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B cells have to get through several selection steps during differentiation from an immature to a mature stage B cell, or into an antibody-secreting cell (reviewed in 1 and 2). Only B cells that have experienced selections are allowed to join a mature B cell pool and to differentiate into antibodysecreting cells with appropriate stimuli. These sdections would enable mice to maintain a stable B cell pool without autoreacrive B cells particularly against cell membrane-anchored stirantigens (2) (3) (4) and to produce effdently antibodies with adequate specificity and affinity (1, 5, 6 ). An execution of these selections would involve apoptosis, survival, or proliferation of B cells. Analysis of double transgenic mice, reported by Goodnow et al. (3 and reviewed in 4) , revealed that apoptosis is critically involved in a negative selection that trims off B cells bearing aberrant specificity against self-antigens. Autoantigen itsdf or in concert with other signals would trigger apoptosis in these hazardous cells. A positive sdection requires a condition where only cells that receive a signal are able to survive or grow. Otherwise, cells undergo apoptosis. In the germinal center, only cells bearing a surface immunoglobulin with suffcient affinity against an antigen are allowed to survive and grow (5) . In this situation, stimulatory signals such as antigen itsdf or the CD40 ligand are shown to protect cells from apoptosis and induce survival or proliferation (5, 6) . In either selection, apoptosis seems to play an essential role, and a decision whether cells undergo apoptosis or are allowed to survive or grow would be the most critical part of the selections. Accordingly a signal that is capable of inducing or blocking apoptosis can be implicated in the pivotal systems for selecting B cells. An identification of a molecule mediating such a signal profoundly contributes to the understanding of the systems underlying B cell selections during their maturation.
Lymphocy~ are one of the most sensitive cells to immediate radiation-induced damage (7) . In contrast to other cell types, quiescent lymphocytes are more sensitive than actively cycling cells, (7, 8) , and the damaged cells are thought to undergo apoptosis. This process does not involve cell division and is referred to as interphase death. It is conceivable that some lymphocyte-specific signaling systems underlie interphase death in irradiation-induced damage, and that these lymphoid cell-specific signaling systems also work at a time when B cells undergo apoptosis during B cell selection. These assumptions prompted us to search for a mAb with radioprotective activity.
In the present study, we established mAb KP/14, which was able to protect B cells from irradiation-dependent apoptoffs. RP/14 mAb was able to drive B cells in culture into cycling as well. The antigen recognized with R.P/14 (the RP antigen) was expressed on mature B cells but not on either immature or pre-B cells. Moreover, B cells from X-linked immunoddident mice (XID) t (9) did not respond to RP/14 for proliferation in spite of comparable expression of the RP antigen with B cells of wild type. The RP antigen was monomeric and 105 kD in size. These results suggest that the RP antigen delivers signals into B cells for blocking apoptosis and proliferation. Moreover, the signal transduction through the RP antigen was shown to be defective in B cells with XID.
Materials and Methods
Mice and Rats. BALB/c and C57BL/6 mice were obtained from Japan SLC Co. (Hamamatsu, Japan), and used at 8-15 wk of age.
CB17 scid/scid mice were from Japan Clea Laboratories Inc. (Tokyo, Japan). Wistar rats were purchased from Charles River Japan Inc. (Yokohama, Japan). All mice and rats were maintained in the An- mAbs. Wistar rats were immunized with spleen cells from BALB/c mice. 3 d after the third immunization, spleen cells of immunized rats were fused with SP2/0 myeloma cells (obtained from the American Type Culture Collection, Rockville, MD). The strategy for screening of mAbs is described in Results section. The established series (RP) of antibodies were all IgG2a/x. The antibody against B220, RA3-6B2 (12) was provided by Dr. Shinya Murakami (Osaka University Dental School, Osaka, Japan). The rat antibodies against mouse IgM (AM/3; IgG2a/x) and IgD (CS/15: IgG2a/K) were established in our laboratory. These antibodies were purified from ascitic fluids from CB17 scid/scid mice that had been transplanted with hybridomas.
Protection from Cell Death by Irradiation, or Dexaraethasone. For expe6_ments of irradiation-induced apoptosis, spleen cells were placed in a 96-wetl plate (2 x 10S/well), and precultured with antibodies (10 gg/ml) for 2 h. Then, cells were irradiated (100 or 200 tad) and cultured for an additional 18 h. As for dexamethasone-induced apoptosis, varying concentrations of dexamethasone (Wako Pure Chemical Industries, Ltd., Osaka, Japan) were added to cultures simultaneously with antibodies, and cells were cultured for 20 h. In these experiments, viable cells were determined after culture by a trypan blue dye exclusion test. Percentages of viable cells were determined by the formula: percent viable cells = 100 x (viable cell number after culture/input cell number). The results were represented as mean + SD for triplicate cultures.
For measuring DNA contents, cells were harvested and fixed with 70% ethanol. Fixed cells were stained with PBS containing 50/zg/ml propidium iodide (Sigma Chemical Co., St. Louis, MO) and 10/~g/ml RNase (Nippon Gene, Toyama, Japan). After washing twice with PBS supplemented with 2% FCS and 0.1% sodium azide, cells were analyzed on a FACScan | (Becton Dickinson & Co., Mountain View, CA).
Cell Pwliferation Assa~,. Spleen cells or T cell-depleted spleen cells were inoculated into a 96-well plate at 2 x 10S/well (10) and cultured with or without mAb (10/~g/ml) for 2-3 d. The cultures were pulsed with 1 #Ci/well of [3H]TdR (ICN Radiochemicals, Irvine, CA) for the last 6 h of the culture. They were then harvested onto glass fiber filters and the incorporated radioactivity was determined in a liquid scintillation counter. The results were presented as the average cpm _+ SD from triplicate wells.
Immunofluorescence Analysis. Cells in suspension (5 x 10 s calls/200 #1) were incubated for 20 rain on ice with mAbs, After two washes, FITC-labded mouse anti-rat ~ (MAR18.5) mAb was added for an additional 20-min incubation. Propidinm iodide was included during this incubation period and used as a gating parameter to exclude dead ceUs. For dual staining, cells were incubated with a biotinylated antibody, and after washing twice, PE-labded avidin (Vector Laboratories Inc., Burlingame, CA) and a FITClabeled antibody were added and incubated for 20 min on ice. In this case, propidium iodide was not included. Labeled cells were then analyzed using a FACScan | (Becton Dickinson & Co.).
Cell Surface Biotinylation and Immunoprecipitation. Cell surface biotinyhtion and immunoprecipitation were carried out as described previously (13) . Briefly, cells (5 x 107/ml) were washed twice with HBSS, and suspended in saline containing 100 mM Hepes (pH 8.0). Sulfosuccinimidobiotin (Pierce Chemical Co., Rockford, IL) was added to call suspension at a concentration of 0.5 mg/ml. After a 40-min incubation at room temperature with occasional shaking, cells were washed and lysed in lysis buffer containing 50 mM Tris/HC1 (pH 7.5), 150 mM NaC1, 1% Triton X-100, 50 mM iodoacetamide, I mM PMSF, 10 gg/ml soybean trypsin inhibitor, 2 mM MgClz, 2 mM CaClz, and 0.1% sodium azide. After a 30-min incubation on ice and following centrifugation, the cell lysates were recovered and incubated with antibody-coupled Sepharose 4B for 2 h at 4~ After washing with lysis buffer, bound proteins were subjected to SDS-PAGE, blotted onto a nitrocellulose membrane, and visualized with avidin-peroxidase (Bio-Rad Laboratories, Richmond, CA) followed by an appropriate substrate.
Results
Radiopwtective Activity ofmAbs. We immunized rats with spleen cells from BALB/c mice, and fused with SP2/0 myeloma cells. In an attempt to search for a molecule that modulates apoptosis, mAbs were screened by an assay system for protective effects from apoptosis caused by low dose irradiation. Mouse spleen cells were cultured with supernatants from resultant hybridoma cells for 2-4 h at 37~ Spleen cells were then irradiated at 100-200 rad, cultured for another 18 h, and viable cells were counted. The supernatants with which more cells remained viable were selected and subjected to a subsequent cloning. Among over 2,000 of resultant hybridoma clones, 5 clones (RP/12, RP/14, RP/15, RP/16, and RP/19) were selected and analyzed in this study because of their remarkable radioprotective activities. Since functional activities of these five hybridoma clones were similar to each other and the antigen recognized with these antibodies appeared identical as judged by flow cytometry and immunoprecipitation experiments, the results obtained with RP/14 are shown in the present study, except the experiments of immunoprecipitation in which the results obtained with RP/14 and RP/16 are shown. Fig. 1 , one of representative results of a series of experiments repeated more than five times, showed the radioprotective activity of RP/14. Two to three times more spleen cells remained viable with RP/14 than those without antibody or with a control antibody. Then DNA contents of irradiated cells were examined with an aim to analyze apoptotic cells, because cells with subdiploid DNA corresponded to those undergoing apoptosis (14) . For this experiment, irradiated spleen cells were harvested at earlier periods of time I. Radioprotective activity of ILP/14 on spleen cells. Spleen cells from C57BL/6 mice were cultured for 2 h with or without an antibody before irradiation. Isotype-matched rat anti-mouse B220 mAb (ILA3-6B2) was used as a control antibody. Subsequently cells were cultured for 18 h. Viable cells were counted by trypan blue dye exclusion, and percent viable calls are shown. The values are mean _+ SD for triplicate cultures.
(6 or 12 h) after the irradiation, because in apoptotic cells, nuclear changes including D N A degradation precedes cell membrane death (15) , and cells undergoing D N A degradation still exclude trypan blue. As shown in Fig. 2 , an inclusion of RP/14 reduced cells with subdiploid D N A in percentage. The radioprotective effect of RP/14 was more remarkable at 6 h after irradiation than that at 12 h after irradiation (Table 1) . When cells were incubated on ice for 6 h after irradiation, as little as 0.6% of cells showed subdiploid DNA. Therefore D N A degradation is a metabolically active process, and RP/14 seemed to disturb this process. At higher dose irradiation of 2,000 rad, spleen cells were shown to die by necrosis rather than apoptosis (8) . Under these conditions, RP/14 did not rescue spleen cells from irradiation-induced damage (data not shown). We also induced cell death by apoptosis using dexamethasone (16) and examined the effect of RP/14 on its protection. RP/14 was again effective in rescuing spleen cells from dexamethasone-induced cell death (Hg. To analyze in more detail, dual staining was carried out with cells from spleen or bone marrow using various mAbs (Fig. 4) . The expression of the RP antigen in spleen cells was restricted on B220-positive cells (Fig. 4 A) Spleen cells from BALB/c mice were cultured with RP/14 or control antibody (10 #g/ml) for 2 h before irradiation (200 rad). them, cells expressing the tLP antigen appeared to bear bright B220, dull IgM, and bright IgD (Fig. 4, A, C, and E) . This phenotype represents rather mature and long-lived B cells (17) (18) (19) .
In bone marrow, the RP antigen was expressed on B cells expressing bright B220 (Fig. 4 B) , and dull IgM (Fig. 4 D) , but not on pre-B cells, because the RP antigen was not expressed on either B220 au" or IgM-negative cells. B cells in bone marrow with bright B220 and dull IgM are reported to be derived from long-lived recirculating B cells but not from newly generated B cells (17, 18) . Therefore the expression pattern of the RP antigen in bone marrow would be consistent with that in spleen. Collectively, the RP antigen (Fig. 6) . Indeed, blasts generated by culturing with RP/14 expressed the RP antigen. These blasts retained other B cell markers including B220, IgM, and IgD (data not shown). Thus, it would be B cells expressing the RP antigen that showed blastic change and were rescued from irradiation-or dexamethasone-dependent apoptosis.
The uptake of [3H]TdR was examined to determine whether or not blastic change of B cells achieved with RP/14 proceed to B cell proliferation. As shown in Table 2 , spleen cells showed remarkable uptake of [3H]TdR upon stimulation with RP/14. The response peaked around day 2-4, and Figure 5 . RP mAbs recognize a monomeric molecule with 105 kD molecular mass. B lymphoma cell, BCL1, was surfacebiotinyhted, detergent-extracted, and precipitated with RP/14-or RP/16-bound beads. Bound proteins were subjected to SDS-PAGE (9% acrylamide) under a reduced condition, blotted onto a nitrocellulose membrane, and detected with avidin-peroxidase and appropilate substrates. then gradually declined (data not shown). We obtained similar proliferative responses by using T cell-depleted spleen cells (Table 3) . Moreover, spleen cells did increase in number when RP mAb was added to culture (data not shown). Thus, RP/14 appeared to drive B cells into proliferation. After stimulation with RP/14, supematant from spleen cells were collected and the amount of IgM was determined by ELISA. No significant production of IgM was observed (data not shown). respond to RP/14 mAb as judged by [3H]TdR uptake ( Because responding B cells are positive for the RP antigen, RP/14 would deliver a signal into mature B cells through the RP antigen. To our knowledge, no molecule with similar molecular weight and expression profiles is reported, although NH2-terminal amino acid sequencing and isolation of cDNA for the RP antigen is required to define that the RP antigen is novel.
B Cells with XID Do Not Respond to RP mA b in Spite of Comparable Expression of the RP Antigen to B Cells of Wild Typ~
In contrast to other cell types, lymphocytes in a quiescent state are more vulnerable to irradiation-induced apoptosis than those in an actively dividing state (7, 8) . Activation makes B cells resistant to irradiation (8) . RP/14 protected B cells from irradiation-induced apoptosis. At the same time RP/14 activated B cells as judged by a blastic change and drove them into proliferation. Moreover, both rescued cells and blastic cells expressed the RP antigen. Therefore B cell activation and protection from apoptosis by RP/14 would be explained by a signal generated by RP/14. In other words, radioprotective activity by RP/14 would stem from B cell activation by RP/14. A signal delivered with RP/14 through the RP antigen activates B cells, and activated B cells then would turn resistant against irradiation-induced apoptosis. Accordingly, protection from apoptosis, a blastic change, and [3H[TdR uptake, all these readout systems would observe one phenomenon, B cell activation achieved by a signal with RP/14.
Signals to B cells delivered by RP/14 mAb appear to be similar to that delivered by the antibody against CD40 (21) . Although a mAb against murine CD40 has not been reported yet, the antibody against human CD40 is able to induce B cell proliferation and immunoglobulin secretion particularly in concert with antigen or anti-IgM, and cytokines such as IL-4 or IL-10 (22, 23). Moreover, anti-CD40 has been shown to protect germinal center cells from apoptosis (6) , and a B cell line, WEHI231, from anti-IgM-mediated apoptosis (24) . The signal through CD40 into B cells results in both activation and protection from apoptosis, phenomena as were observed with the RP antigen. It is interesting to study the effect of RP/14 on anti-IgM-mediated apoptosis of WEHI231 cells (24) .
The RP antigen can be, however, discriminated from CD40 by the fact that the RP antigen is expressed on B220b~ig ht IgM a~ IgDb~ ht B cells, but not on pre-B cells or immature B cells. On the contrary, an acquisition of human CD40 precedes the expression of CD20, and shows a pan-B reactivity in peripheral lymphoid organs (22) . CD40 is expressed on germinal center cells (6) , and plays critical roles in germinal center formation (5, 6, (25) (26) (27) (28) (29) . However, it is unlikely that germinal center cells possess the bright expression of the RP antigen, because the RP antigen is expressed on IgD-positive B cells (Fig. 4) , which do not reside in germinal center (6) . The restricted expression of the RP antigen in B cell ontogeny might suggest a very specified role of the RP antigen in B cell activation or maturation as compared with CD40.
It is well acknowledged that immature B cells in spleen can be discriminated from mature B cells on the basis of differential expression of B220, surface IgM, and surface IgD (17) (18) (19) . B cells with B220 d~l, IgMb'ig ht, and IgD aun are supposed to belong to an immature B cell population that would be recently generated in the bone marrow. Long-lived mature B cell subpopulation has B220b'ig ht, IgM aun, and IgDb~ hr. Cell labeling studies with 5-bromo-2'-deoxyuridine (BrdU) revealed that the immature B cell population has rapid turn over rate whereas the mature B cell population is stable (18) . Consequently it is assumed that some maturation stages exist between immature B cells and mature long-lived B cells (19) . Although more information is required concerning the precise expression pattern of the RP antigen in association with other markers such as the heat stable antigen (19) , it could be a transition stage from immature to mature B cells where the ILP antigen is acquired. In this regard, RP/14 would be useful as a novel marker for this transition stage. Moreover, because RP/14 is shown to deliver a signal into IgM-positive, IgD-positive B cells, the RP antigen itself might be, in some ways, implicated in this transition. Further studies are ongoing to elucidate these issues.
Mice with XID (9) lack a mature B cell population that normally develops late in ontogeny and expresses low IgM and high IgD (20) . B cell maturation seemed to be arrested at a stage between immature and mature B cells. Taking the expression pattern of the RP antigen into consideration, we were interested in investigating the KP antigen on xid B cells. Although B220-positive B cells with x/d does express the RP antigen comparably to wild-type B cells (Fig. 6) , B cells with xiddo not respond to the signal with RP/14. Recently a gene involved in X-linked agammaglobulinemia was identified (30, 31) . The gene, btk which encodes a member of the src family of protein tyrosine kinases was mapped to the x/d region of the mouse X chromosome. A single conserved residue within the NH2-terminal unique region of Bruton's tyrosine kinase (Btk) was mutated in xid mice (32) . Btk, for which the btk gene code is supposed to work in signal transmission which is indispensable for B cell maturation in human and mice. The results in the present study might suggest an indispensable role of Btk in transducing the signal with RP/14 mAb. However it is also possible that a mutation in Btk indirectly affects a signaling complex used by activation with RP/14 mAb.
While B cell production is intact (33, 34) , mice with xid have a difficulty in maintaining a stable B cell pool in peripheral lymphoid organs especially in competition with wildtype B cells (35) . Maturation into a long-lived mature B cell would be prerequisite for joining a stable B cell pool. The acquisition of the RP antigen by B cells would occur at a transitory state from an immature to a mature state. Taken together with these issues, it would be possible that the signal through the RP antigen is involved in maturation itself or in maintaining a long-lived B cell pool. In this regard, the study of the RP antigen and the signal transduction through the RP antigen would be able to contribute to further understanding of B cell maturation and activation in peripheral lymphoid organs.
